Article Sidebar

Submitted
Oct 25, 2024
Published
Oct 25, 2024
Download
PDF
Statistic
Read Counter : 49 Download : 22

Main Article Content

Abstract

Obesity is a complex multifactorial disease that accumulated excess body fat leads to negative effects on health. Obesity continues to accelerate resulting in an unprecedented epidemic that shows no significant signs of slowing down any time soon. Raised body mass index (BMI) is a risk factor for noncommunicable diseases such as diabetes, cardiovascular diseases, and musculoskeletal disorders, resulting in dramatic decrease of life quality and expectancy. The main cause of obesity is long-term energy imbalance between consumed calories and expended calories. Here, we explore the biological mechanisms of obesity with the aim of providing actionable treatment strategies to achieve a healthy body weight from nature to nurture. This review summarizes the global trends in obesity with a special focus on the pathogenesis of obesity from genetic factors to epigenetic factors, from social environmental factors to microenvironment factors. Against this background, we discuss several possible intervention strategies to minimize BMI.          

Keywords

obesity epidemiology pathophysiology genetics epigenetics microenvironment

Article Details

How to Cite
G. Kiran, M. Ramya Brahmaini, M. SaiLikitha, P. Hemalatha, B.V.Veeranjineyulu, & M.Mallikarjuna. (2024). A Study on Drug therapy for obesity and its risk factors. International Journal of Research in Pharmacology & Pharmacotherapeutics, 13(4), 447-453. Retrieved from https://ijrpp.com/ijrpp/article/view/576
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. 1. Qureshi K, Abrams GA. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2007;13:3540–53.
  2. 2. World Health Organization, Global health observatory (GHO) data.http://www.who.int/gho/ncd/risk_factors/obesity_text/en/index.html. Accessed 7 Jan 2017.Alternanthera sessilis L Alternanthera sessilis L
  3. 3. Artham SM, Lavie CJ, Milani RV, Ventura HO. The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med. 2008;120:34–41.Alternanthera sessilis L Alternanthera sessilis L
  4. 4. Pagotto U, Vanuzzo D, Vicennati V, Pasquali R. Pharmacological therapy of obesity. Ital J Cardiol. 2008;9:83–93.Alternanthera sessilis L Alternanthera sessilis L
  5. 5. Fried M, Hainer V, Basdevant A, Buchwald H, Dietel M, Finer N, Greve JW, Horber F, Mathus-Vliegen E, Scopinaro N, Steffen R, Tsigos C, Weiner R, Widhalm K. Interdisciplinary European guidelines on surgery for severe obesity. Rozhl Chir. 2008;87:468–76.Alternanthera sessilis L Alternanthera sessilis L
  6. 6. Azman KF, Amom Z, Azlan A, Esa NM, Ali RM, Shah ZM, Kadir KK.Alternanthera sessilis L Antiobesity effect of Tamarindus indica L. pulp aqueous extract in high-fatAlternanthera sessilis L diet-induced obese rats. J Nat Med. 2011;66:333–42.Alternanthera sessilis L Alternanthera sessilis L
  7. 7. Thurairajah PH, Syn WK, Neil DA, Stell D, Haydon G. Orlistat (xenical)Alternanthera sessilis L induced subacute liver failure. Eur J Gastroenterol Hepatol. 2005;17:1437–8.Alternanthera sessilis L Alternanthera sessilis L
  8. 8. Yun JW. Possible anti-obesity therapeutics from nature–A review.Alternanthera sessilis L Phytochemistry. 2010;71:1625–41.Alternanthera sessilis L Alternanthera sessilis L
  9. 9. Slanc P, Doljak B, Kreft S, Lunder M, Janes D, Strukelj B. Screening ofAlternanthera sessilis L selected food and medicinal plant extracts for pancreatic lipase inhibition.Alternanthera sessilis L Phytother Res. 2009;23:874–7.Alternanthera sessilis L Alternanthera sessilis L
  10. 10. Perumal V, Azizah AH, Ismail A, Saari K, Abas F, Ismail IS, Maulidiani H, LajisAlternanthera sessilis L N, Khatib A. Effect of Cosmos caudatus Kunth Leaves on the lipid profile of aAlternanthera sessilis L hyperlipidemia-induced animal model. J Food Chem Nutr. 2014;2:43–51.Alternanthera sessilis L Alternanthera sessilis L
  11. 11. Amalia L, Anggadired KS, Fidrianny I, Inggriani R. Antihypertensive PotencyAlternanthera sessilis L of Wild Cosmos (Cosmos caudatus Kunth, Asteraceae) Leaf Extract.Alternanthera sessilis L J Pharmacol Toxicol. 2012;7:359–68.Alternanthera sessilis L Alternanthera sessilis L Chapter VII Reference
  12. 12. Loh SP, Hadira O. In vitro inhibitory potential of selected Malaysian plantsAlternanthera sessilis L against key enzymes involved in hyperglycemia and hypertension.Alternanthera sessilis L Malays J Nutr. 2011;17:77–86.Alternanthera sessilis L
  13. 13. Lee YA, Cho EJ, Tanaka T, Yokozawa T. Inhibitory activities ofAlternanthera sessilis L proanthocyanidinis from persimmon against oxidative stress and digestiveAlternanthera sessilis L enzyme related to diabetes. J Nutr Sci Vitaminol. 2007;53:287–92.Alternanthera sessilis L
  14. 14. Cheng SHH, Ismail A, Anthony J, Ng OC, Hamid AA, Barakatun-Nisak MY.Alternanthera sessilis L Eight Weeks of Cosmos caudatus (Ulam Raja) Supplementation ImprovesAlternanthera sessilis L Glycemic Status in Patients with Type 2 Diabetes: A Randomized ControlledAlternanthera sessilis L Trial. Evid Based Complement Alternat Med. 2015;2015:1–7. Article ID 405615.Alternanthera sessilis L
  15. 15. Mediani A, Abas F, Khatib A, Tan CP. Cosmos caudatus as a potential sourceAlternanthera sessilis L of polyphenolic compounds: Optimisation of oven drying conditions andAlternanthera sessilis L characterisation of its functional properties. Molecules. 2013;18:10452–64.Alternanthera sessilis L
  16. 16. Seo MJ, Lee YJ, Hwang JH, Kim KJ, Lee BY. The inhibitory effects ofAlternanthera sessilis L quercetin on obesity and obesity-induced inflammation by regulation ofAlternanthera sessilis L MAPK signaling. J Nutr Biochem. 2015;26:1308–16.Alternanthera sessilis L
  17. 17. Hsu CL, Wu CH, Huang SL, Yen GC. Phenolic compounds rutin andAlternanthera sessilis L o-coumaric acid ameliorate obesity induced by high-fat diet in rats.Alternanthera sessilis L J Agric Food Chem. 2009;57:425–31.Alternanthera sessilisl.
  18. 18. (Zheng et al., 2010; Mukherjee, 2003; Thomson et al., 1997; Shi and Burn, 2004).
  19. 19. (Hardeman et al., 2000).
  20. 20. (Abdollahi and Afshar-Imani, 2003).
  21. 21. Park and Kim, 2011; Perez-Vizcaino et al., 2006).